Eddie Reed

Title: Eddie Reed: Innovator in Cancer Treatment

Introduction

Eddie Reed is a notable inventor based in Germantown, MD (US), recognized for his contributions to cancer treatment. He holds 5 patents that focus on innovative methods for addressing ovarian cancers and improving chemotherapy sensitivity.

Latest Patents

Among his latest patents, Reed has developed a method for treating ovarian cancers with cadmium. He has also created an assay for determining the sensitivity of tumors to DNA-platinating chemotherapy. Additionally, his work includes an assay of the mRNA levels of ERCC1 and XPAC, two genes involved in DNA repair. This method provides insights into the sensitivity of tumors to platinum-based chemotherapy. Tumors resistant to cisplatin often express high levels of ERCC1 mRNA, particularly exon VIII. Concurrent expression of ERCC1 and XPAC mRNAs can also indicate cisplatin resistance in certain tumor types.

Career Highlights

Reed has worked with the United States of America as represented by the Department of Health and the National Institutes of Health, a component of the US Department of Health & Human Services. His work in these esteemed institutions has significantly contributed to advancements in cancer research and treatment methodologies.

Collaborations

Eddie Reed has collaborated with notable professionals in his field, including Elise C Kohn and Kang Bo Lee. Their combined expertise has furthered the development of innovative cancer treatment solutions.

Conclusion

Eddie Reed's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patents and collaborations highlight his commitment to improving patient outcomes through scientific advancements.